| Literature DB >> 23721787 |
Jade M Franklin1, Matt Mathew, Gonzalo A Carrasco.
Abstract
Recent behavioral reports suggest that repeated exposure to cannabis and synthetic cannabinoid agonists is linked with mental disorders associated with dysfunction of serotonin 2A (5-HT2A) receptor neurotransmission such as anxiety and depression. Here, we studied the effect of a nonselective cannabinoid agonist, CP55940, on the activity of 5-HT2A receptors in hypothalamic paraventricular nucleus (PVN). We detected that repeated exposure to CP55940 enhanced the prolactin and corticosterone neuroendocrine responses mediated by 5-HT2A receptors and increased the membrane-associated levels of 5-HT2A receptors in PVN. Importantly, we also detected increased anxiety-like behaviors in CP55940 treated rats compared to controls. The data presented here suggest that the mechanisms mediating the cannabinoid-induced upregulation of 5-HT2A receptors would be brain-region specific, as we were unable to detect a CP55940-induced upregulation of 5-HT2A mRNA. Our results might provide insight into the molecular mechanism by which repeated exposure to cannabinoids could be associated with the pathophysiology of neuropsychiatric disorders.Entities:
Keywords: (−) DOI; (−)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol; 5-HT; 5-HT(2A); 5-HT(2A) receptor; 5-hydroxytryptamine; CP 55,940; ERK; G-proteins; Hypothalamus; Marijuana; PVN; Serotonin; [(−)-1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane HCl]; extracellular kinase; hypothalamic paraventricular nucleus; serotonin 2A; Δ(9)-THC; Δ(9)-tetrahydrocannabinol
Mesh:
Substances:
Year: 2013 PMID: 23721787 PMCID: PMC3735609 DOI: 10.1016/j.neulet.2013.05.039
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046